Straits Research Highlights Rapid Growth in the Global Preterm Birth and PROM Testing Market
Market Size and Forecast The global preterm birth and PROM (Premature Rupture of Membranes) testing market is witnessing remarkable growth. Valued at USD 1,662.57 million in 2022, it is projected to expand at a robust CAGR of 16.33% during the forecast period (2023–2031), reaching USD 2,169.27 million by 2031.
For a comprehensive understanding, download the full PDF sample copy of the report: https://straitsresearch.com/report/preterm-birth-and-prom-testing-market/request-sample
Market Definition Preterm birth and PROM testing involve diagnostic methods and tools to identify risks related to preterm labor and the rupture of membranes before term. These tests play a crucial role in mitigating risks to maternal and fetal health, ensuring timely medical intervention.
Market Dynamics
Key Trends:
Growing Adoption of Point-of-Care Testing: The convenience and speed of point-of-care diagnostic tools are driving their adoption in prenatal care, enabling timely and accurate decision-making.
Advancements in Biomarker Research: Continuous research into innovative biomarkers is enhancing the sensitivity and specificity of PROM and preterm birth testing solutions.
Market Drivers:
Rising Prevalence of Preterm Births: The increasing incidence of preterm deliveries globally is boosting the demand for effective testing methods.
Increased Healthcare Expenditure: Improved access to healthcare and higher spending in emerging economies are driving the market growth.
Market Opportunities:
Emerging Markets in Asia Pacific: Rapidly developing healthcare infrastructure and growing awareness about maternal and child health in this region present significant growth opportunities.
Technological Innovations: Continuous advancements in diagnostic technologies and the introduction of novel testing methods offer potential for market expansion.
Market Segmentation The market is segmented based on test types:
Pelvic Examination
Ultrasound
Biochemical Markers
Uterine Monitoring
Nitazine Test, Ferning Test
Pooling
PAMG-1 Immunoassay
IGFBP Test
Fetal Fibronectin (fFN)
Others
Access detailed segmentation here: https://straitsresearch.com/report/preterm-birth-and-prom-testing-market/segmentation
Regional Insights
Dominated Region: North America leads the market, attributed to advanced healthcare systems, significant research investments, and high awareness levels among healthcare providers and patients.
Fastest Growing Region: The Asia Pacific region is poised for rapid growth, driven by increasing healthcare expenditure, improving infrastructure, and heightened awareness of prenatal care.
Key Players Prominent players in the global preterm birth and PROM testing market include:
Qiagen N.V.
Hologic Inc.
Coopersurgical Inc.
Abbott
Medix Biochemica
Sera Prognostics
Clinical Innovations LLC
Biosynex
NX Prenatal
I.Q. Products
Conclusion The global preterm birth and PROM testing market is set to expand significantly, driven by technological advancements, rising healthcare investments, and increasing awareness about maternal and fetal health. With North America leading the way and Asia Pacific emerging as a high-growth region, the market presents substantial opportunities for stakeholders.
For more information, queries, or customization options before purchasing the report, visit: https://straitsresearch.com/buy-now/preterm-birth-and-prom-testing-market
